StockData
Pulmonx Corp logo

Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.69−0.04 (-1.65%)

Close on Nov 18, 2026Market cap $115.53MP/E –Yield –

Pulmonx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Pulmonx's shares outstanding was 42M at Jun 30, 2026. For fiscal 2025 it was 41M, up 4.0% from the year before. The highest annual figure on record is 41M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202541M+4.0%
FY2024Dec 31, 202439M+3.0%
FY2023Dec 31, 202338M+2.4%
FY2022Dec 31, 202237M+2.7%
FY2021Dec 31, 202136M+254.7%
FY2020Dec 31, 202010M+473.4%
FY2019Dec 31, 20192M+6.1%
FY2018Dec 31, 20182M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202642M+5.0%
Q1 FY2026Mar 31, 202642M+4.9%
Q4 FY2025Dec 31, 202541M+4.6%
Q3 FY2025Sep 30, 202541M+4.2%
Q2 FY2025Jun 30, 202540M+3.8%
Q1 FY2025Mar 31, 202540M+3.4%
Q4 FY2024Dec 31, 202440M+3.1%
Q3 FY2024Sep 30, 202439M+3.0%
Q2 FY2024Jun 30, 202439M+3.0%
Q1 FY2024Mar 31, 202439M+2.8%
Q4 FY2023Dec 31, 202338M+2.7%
Q3 FY2023Sep 30, 202338M+2.5%
Q2 FY2023Jun 30, 202338M+2.2%
Q1 FY2023Mar 31, 202338M+2.1%
Q4 FY2022Dec 31, 202237M+2.0%
Q3 FY2022Sep 30, 202237M+2.0%
Q2 FY2022Jun 30, 202237M+2.7%
Q1 FY2022Mar 31, 202237M+4.1%
Q4 FY2021Dec 31, 202137M+1201.8%
Q3 FY2021Sep 30, 202136M+1783.3%
Q2 FY2021Jun 30, 202136M+1790.3%
Q1 FY2021Mar 31, 202135M+1777.2%
Q3 FY2020Sep 30, 20203M+56.4%
Q2 FY2020Jun 30, 20202M–
Q1 FY2020Mar 31, 20202M–
Q4 FY2019Dec 31, 20192M–
Q3 FY2019Sep 30, 20192M–

More Pulmonx figures

See a number that looks wrong?